CytomX Therapeutics
CTMX
CTMX
62 hedge funds and large institutions have $308M invested in CytomX Therapeutics in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
62
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$16.4M | |
| 2 | +$6.48M | |
| 3 | +$1.83M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.64M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$1.38M |
Top Sellers
| 1 | -$7.58M | |
| 2 | -$3.28M | |
| 3 | -$1.67M | |
| 4 |
EA
Emerald Acquisition
Seattle,
Washington
|
-$342K |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$301K |